GB1404324A - Process for the diagnosis of chronic hypercyanogenesis - Google Patents
Process for the diagnosis of chronic hypercyanogenesisInfo
- Publication number
- GB1404324A GB1404324A GB4261872A GB4261872A GB1404324A GB 1404324 A GB1404324 A GB 1404324A GB 4261872 A GB4261872 A GB 4261872A GB 4261872 A GB4261872 A GB 4261872A GB 1404324 A GB1404324 A GB 1404324A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hypercyanogenesis
- chronic
- diagnosis
- hydroxocobalamine
- cyanocobalamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000001684 chronic effect Effects 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 1
- 235000000639 cyanocobalamin Nutrition 0.000 abstract 2
- 239000011666 cyanocobalamin Substances 0.000 abstract 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 abstract 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 abstract 2
- 235000004867 hydroxocobalamin Nutrition 0.000 abstract 2
- 239000011704 hydroxocobalamin Substances 0.000 abstract 2
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 abstract 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- 239000003708 ampul Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000006303 photolysis reaction Methods 0.000 abstract 1
- 230000015843 photosynthesis, light reaction Effects 0.000 abstract 1
- 210000002700 urine Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/17—Nitrogen containing
- Y10T436/172307—Cyanide or isocyanide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7133923A FR2153156B1 (enExample) | 1971-09-21 | 1971-09-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1404324A true GB1404324A (en) | 1975-08-28 |
Family
ID=9083255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4261872A Expired GB1404324A (en) | 1971-09-21 | 1972-09-14 | Process for the diagnosis of chronic hypercyanogenesis |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3903253A (enExample) |
| BE (1) | BE788780A (enExample) |
| DE (1) | DE2246162B2 (enExample) |
| FR (1) | FR2153156B1 (enExample) |
| GB (1) | GB1404324A (enExample) |
| LU (1) | LU66073A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4173618A1 (en) | 2021-10-29 | 2023-05-03 | Original Biomedicals Co., Ltd. | Composition for upper respiratory tract administration comprising a metal chelator and a cyanide antidote and method thereof |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4279886A (en) * | 1979-01-02 | 1981-07-21 | University Patents, Inc. | Test for pancreatic exocrine function |
| BE1007839A6 (nl) * | 1993-12-20 | 1995-10-31 | Merkus Franciscus W H M Prof | Farmaceutische compositie voor de nasale toediening van hydroxocobalamine. |
| US5925625A (en) * | 1994-05-13 | 1999-07-20 | Merkus; Franciscus W. H. M. | Pharmaceutical composition for the intranasal administration of hydroxocobalamin |
| FR2740973B1 (fr) * | 1995-11-15 | 1998-02-06 | Lipha | Nouvelle forme d'administration de l'hydroxocobalamine et son utilisation dans les intoxications par les cyanures |
| US9585908B1 (en) | 2010-11-08 | 2017-03-07 | Chromaceutical Advanced Technologies, Inc. | Collyrium composition and method of using same |
-
0
- BE BE788780D patent/BE788780A/xx not_active IP Right Cessation
-
1971
- 1971-09-21 FR FR7133923A patent/FR2153156B1/fr not_active Expired
-
1972
- 1972-09-13 LU LU66073A patent/LU66073A1/xx unknown
- 1972-09-14 GB GB4261872A patent/GB1404324A/en not_active Expired
- 1972-09-15 US US289291A patent/US3903253A/en not_active Expired - Lifetime
- 1972-09-20 DE DE19722246162 patent/DE2246162B2/de active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4173618A1 (en) | 2021-10-29 | 2023-05-03 | Original Biomedicals Co., Ltd. | Composition for upper respiratory tract administration comprising a metal chelator and a cyanide antidote and method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2153156B1 (enExample) | 1975-10-10 |
| FR2153156A1 (enExample) | 1973-05-04 |
| US3903253A (en) | 1975-09-02 |
| DE2246162A1 (de) | 1973-03-29 |
| LU66073A1 (enExample) | 1973-01-17 |
| DE2246162B2 (de) | 1976-07-22 |
| BE788780A (fr) | 1973-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1330878A (en) | Ketamine resolution | |
| GB1160405A (en) | Method for Promoting Chemical Reactions. | |
| ES2032905T3 (es) | Sistema terapeutico transcutaneo. | |
| GB1404324A (en) | Process for the diagnosis of chronic hypercyanogenesis | |
| GB1167993A (en) | Novel Chemical Compounds, Process for Making Same and Method of Treatment | |
| CA981395A (en) | Process for the discontinuous copolymerization of conjugated dienes containing at most five carbon atoms, and vinylaromatic compounds | |
| Loewe et al. | A new method of administering heparin. | |
| IE35215L (en) | Polynucleotides. | |
| GB1368506A (en) | Process for preparing cyanoethylated ketones | |
| Rogers et al. | Depression of cerebral metabolism by stimulant doses of cocaine. | |
| Grovenstein et al. | Carbanions. VI. The Mechanism of Rearrangement of 2, 2, 2-Triphenylethyllithium and 2, 2, 3-Triphenylpropyllithium | |
| Sacks | Some factors influencing phosphate turnover in muscle | |
| GB1230705A (enExample) | ||
| GB1415333A (en) | Insulin derivatives | |
| ES392309A1 (es) | Un procedimiento para la preparacion de oximas. | |
| GB1449070A (en) | Aminotetralins and use in inducing anesthesia | |
| Roizin et al. | Lithium neurotoxicologic effects: I. Acute phase (preliminary observations). | |
| GB1204803A (en) | Novel pyrroline derivatives and a process for the manufacture thereof | |
| Abuzzahab | Treatment of acute schizophrenia with molindone. | |
| SU1268168A1 (ru) | Способ лечени деструктивного туберкулеза легких | |
| Lamson et al. | Blocking by benodaine of the potassium effect of the return to sleep on awakening from barbiturate anesthesia | |
| GB923336A (en) | Improvements in or relating to steroids and the preparation thereof | |
| MlYAHARA | (6) Catecholamines in Pathogenesis of Ischemic Heart Disease | |
| Glick et al. | Pseudopregnancy: Treatment of periodic psychiatric illness: A pilot study. | |
| Lindholm et al. | Comparison of conventional neuroleptic therapy with depot neuroleptics: An attempt at economic evaluation. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |